Bashir J, Yarube I U
Department of Internal Medicine, Aminu Kano Teaching Hospital, Kano, Nigeria.
Neuroscience and Pathophysiology Unit, Department of Human Physiology, Bayero University, Kano, Nigeria.
IBRO Neurosci Rep. 2022 Feb 17;12:182-187. doi: 10.1016/j.ibneur.2022.02.003. eCollection 2022 Jun.
There is paucity of information on the prevalence of mild cognitive impairment (MCI) among individuals with type 2 diabetes mellitus (T2DM) in sub-Saharan Africa, including Nigeria. In addition, the role of hyperinsulinaemia in the development of MCI needs further investigation. This study sought to assess cognition and hyperinsulinaemia, with the associated characteristics in patients with advanced T2DM. Cognition was assessed using Montreal cognitive assessment test (MoCA), while fasting plasma insulin was measured using an ELISA kit. Sixty one diabetic subjects and 32 non-diabetic controls, matched for age, gender and level of education were studied. The diabetics had MCI while the controls had normal cognitive function. About 88.5% of the diabetic subjects had MCI, in contrast with only 50% of the non-diabetic controls. The most significantly affected cognitive domains among the diabetics were executive function, naming, attention, abstraction and delayed recall. Among the diabetics, MCI correlated with age, weight and body mass index (BMI); and in addition, age and weight found to be significant predictors of MCI. Plasma insulin concentration among the diabetics (16.24 ± 13.5 µIU/ml) was more than twice that of the controls (7.59 ± 2.9 µIU/ml). Hyperinsulinaemia among the diabetics correlated with weight, BMI, blood pressure and fasting blood sugar (FBS). Glycated haemoglobin and FBS levels were higher among diabetics compared with the controls. In conclusion, Africans with advanced T2DM show multi-domain MCI high prevalence, coexisting with hyperinsulinaemia. Majority of the patients have diabetic complications and poor glycaemic control. Hyperinsulinaemia may play a complementary role in the pathophysiology of MCI in T2DM.
在撒哈拉以南非洲地区,包括尼日利亚,关于2型糖尿病(T2DM)患者中轻度认知障碍(MCI)患病率的信息匮乏。此外,高胰岛素血症在MCI发生发展中的作用尚需进一步研究。本研究旨在评估晚期T2DM患者的认知功能和高胰岛素血症及其相关特征。使用蒙特利尔认知评估测试(MoCA)评估认知功能,采用酶联免疫吸附测定试剂盒测量空腹血浆胰岛素水平。研究纳入了61名糖尿病受试者和32名非糖尿病对照者,他们在年龄、性别和教育程度上相匹配。糖尿病患者存在MCI,而对照者认知功能正常。约88.5%的糖尿病受试者患有MCI,相比之下,非糖尿病对照者中这一比例仅为50%。糖尿病患者中受影响最显著的认知领域是执行功能、命名、注意力、抽象思维和延迟回忆。在糖尿病患者中,MCI与年龄、体重和体重指数(BMI)相关;此外,年龄和体重是MCI的显著预测因素。糖尿病患者的血浆胰岛素浓度(16.24±13.5µIU/ml)是对照者(7.59±2.9µIU/ml)的两倍多。糖尿病患者中的高胰岛素血症与体重、BMI、血压和空腹血糖(FBS)相关。与对照者相比,糖尿病患者的糖化血红蛋白和FBS水平更高。总之,患有晚期T2DM的非洲人表现出多领域MCI的高患病率,同时伴有高胰岛素血症。大多数患者有糖尿病并发症且血糖控制不佳。高胰岛素血症可能在T2DM患者MCI的病理生理过程中起辅助作用。